Tag: Elixir Medical

TCT 2017: Elixir reveals new drug-eluting stent

Elixir Medical unveiled for the first time its novel stent technology—Dynamx—at the 2017 Transcatheter Cardiovascular Therapeutics (TCT) meeting (29 October–2 November, Denver, USA). A...

TCT 2017: Elixir Medical to reveal “a game-changing metallic drug-eluting stent...

Elixir Medical has revealed details of its programme and activities during the 2017 meeting of the transcatheter cardiovascular therapeutics (TCT; 29 October–2 November, Denver,...

TCT 2016: “Excellent” rates of late lumen loss with Desolve bioresorbable...

Six-month clinical data for Elixir Medical’s bioresorbable scaffold (Desolve) were presented at the 2016 Transcatheter Cardiovascular Therapeutics (TCT) meeting (29 October–2 November, Washington, DC,...

TCT 2016: First live case featuring Desolve NXT scaffold to be...

Elixir Medical has announced that it will showcase the first live case demonstration by transmission in the USA of its Desolve NXT novolimus-eluting bioresorbable...